Delivery Order SPE2DB24D1104-SPE2DB25FXZP0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 50 MG/ML SURECLICKML, a medication, with a ceiling value of $67,714.65 and a performance period through May 21, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,491.29 firm fixed-price contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $104,102.52, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a prescription medication. The contract has a period of performance through June 17, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, and has a firm fixed price ceiling value of $19,054.41. The contract has an ultimate completion date of May 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,036.77, is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 20, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,253.56 firm fixed-price contract is for the supply of ENBREL 50 MG/ML SURECLICKML medical products. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, with a ceiling value of $9,253.56 and a performance period extending to April 2025. The contract is a firm fixed-price delivery order, and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SURECLICKML. The contract has a ceiling value of $57,580.86 and runs through April 3, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,644.86, is for the delivery of Enbrel 50 mg/mL SureClick medication. It is a firm fixed-price contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,352.43, is for the procurement of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical medication. The contract has a firm fixed-price pricing type and a completion date of May 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FXZP0Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $45,627.06, is for the delivery of 4567819735 - ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not set aside and was awarded on April 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.6k | 4/7/25 |